Billionaire Paul Tudor Jones’ 10 Stocks Picks with Huge Upside Potential

7. Zoetis Inc. (NYSE:ZTS)

Tudor Investment Corporation Equity Stake: $25.03 Million

Stock Upside Potential as of May 7: 33.38%

Number of Hedge Fund Holders: 76

Zoetis Inc. (NYSE:ZTS) is a global animal health company that focuses on delivering quality medicines, vaccines, diagnostic products, genetic tests, and services. It is one of billionaire Paul Tudor Jones’ 10 stock picks with huge upside potential for gaining exposure in the healthcare sector. The company is experiencing rising demand for innovative products, according to solid Q1 2025 results.

Sales in the quarter were up 1.4% year-over-year to $2.22 billion, beating analyst estimates of $2.19 billion. Buoyed by the strong product demand, Zoetis Inc. (NYSE:ZTS) has lifted its revenue guidance for the full year to $9.5 billion from $9.3 billion initially forecasted. Adjusted earnings per share in the first quarter came in at $1.48, higher than the $1.40 a share expected. Similarly, the animal healthcare company has raised its full-year EPS guidance by 3.3% to $6.25

Zoetis Inc.’s (NYSE:ZTS) raising its full-year guidance amid a challenging macro environment underscores the strength of its diversified portfolio tailored for various markets and species. Its growth in 2025 will be driven by three key product franchises: Simparica, Dermatology, and Osteoarthritis (OA) Pain. Simparica Trio is experiencing strong adoption as a preferred canine parasiticide. The company has already expanded its label to include prevention of flea tapeworm infections. Apoquel is the company’s flagship dermatology franchise that grew 10% in Q1, emerging as the top-selling dermatology product.